Detailed Information on Publication Record
2024
Euglykemická ketoacidóza asociovaná se SGLT2 inhibitory a DPP4 inhibitory - rozbor kazuistik
ŠITINA, Michal and Vladimír ŠRÁMEKBasic information
Original name
Euglykemická ketoacidóza asociovaná se SGLT2 inhibitory a DPP4 inhibitory - rozbor kazuistik
Name (in English)
Euglycemic ketoacidosis associated with SGLT2 inhibitors and DPP4 inhibitors - discussion of case reports
Authors
ŠITINA, Michal (203 Czech Republic, belonging to the institution) and Vladimír ŠRÁMEK (203 Czech Republic)
Edition
Anesteziologie a intenzivní medicína, Praha, Česká lékařská společnost J.E. Purkyně, 2024, 1214-2158
Other information
Language
Czech
Type of outcome
Článek v odborném periodiku
Field of Study
30223 Anaesthesiology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 0.100 in 2022
Organization unit
Faculty of Medicine
UT WoS
001284895400006
Keywords (in Czech)
glifloziny; SGLT2 inhibitory; euglykemická ketoacidóza; hyperchloremická acidóza; diabetes mellitus
Keywords in English
gliflozins; SGLT2 inhibitors; euglycemic ketoacidosis; hyperchloremic acidosis; diabetes mellitus
Tags
Reviewed
Změněno: 21/8/2024 12:06, Mgr. Tereza Miškechová
V originále
Euglycemic ketoacidosis is a rare but potentially fatal complication of treatment with SGLT2 inhibitors (gliflozins). However, similar euglycemic ketoacidosis may rarely occur with other antidiabetic drugs or conditions such as pregnancy or alcohol abuse. We describe 3 cases of our patients with euglycemic ketoacidosis associated with gliflozins and 1 case associated with the DPP4 inhibitor sitagliptin and discuss in detail the acid-base disturbances present and the distinction of euglycemic ketoacidosis from classical ketoacidosis in type 1 diabetes.
In English
Euglycemic ketoacidosis is a rare but potentially fatal complication of treatment with SGLT2 inhibitors (gliflozins). However, similar euglycemic ketoacidosis may rarely occur with other antidiabetic drugs or conditions such as pregnancy or alcohol abuse. We describe 3 cases of our patients with euglycemic ketoacidosis associated with gliflozins and 1 case associated with the DPP4 inhibitor sitagliptin and discuss in detail the acid-base disturbances present and the distinction of euglycemic ketoacidosis from classical ketoacidosis in type 1 diabetes.